Menu

YieldMax TSLA Option Income Strategy ETF TSLY

Full chart Compare
Set alert

Price alert · TSLY

All alert types
20.03 USD +0.81 (+4.21%)

At closeNov 6, 2026, 7:51 PM EST

20.28 +0.25 +1.25%

After hours · Nov 6, 7:51 PM ET

19.47 Day range 20.36
19.22 52-week range 41.25
YTD
-46.64%
1 year
-51.38%

Discussion (43)

Sign in to join the discussion

Daniel Otero TSLY 1 year ago #11

Can anyone confirm a dividend will be paid this month? Ex dividend date is 4-17, and the dividend history so far has been consistent but I can’t find an amount that will be paid yet.

Philip TSLY 1 year ago #16

Frank is so right TSLA IS soaring and this is going up pennies. Not sure why.

VICKY HANUKA TSLY 3 years ago #18

$PTC Therapeutics(PTCT.US)$ ?????????????? Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.

Elvis TSLY 3 years ago #19

TD Ameritrade Tsly dividend just hit my account.

Kevin Bowen TSLY 3 years ago #20

It’s interesting how people blame Biden for their inability to make money in the market. What makes it more interesting is how the market as a whole is also at higher levels than ever under previous administration.